Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas
NCT03231306Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2017
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of binimetinib in neurofibromatosis type 1 (NF1), plexiform neurofibroma (PN), sponsored by University of Alabama at Birmingham. Started Nov 2017; status: completed.
02
Drugs
binimetinib
03
Conditions
neurofibromatosis type 1 (NF1)plexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT03231306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03231306.